Eda ÇalişkanYildirim

6PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 21, 2026
Multicenter Real-World Evaluation of Neoadjuvant Carboplatin in Triple-Negative Breast Cancer.

|Oct 29, 2025
Impact of Tumor Localization on Early Recurrence After Curative Resection in Pancreatic Ductal Adenocarcinoma.

Eda Caliskan Yildirim, Ilkay Tugba Unek, Ilhan Oztop

|Sep 27, 2025
Impact of Adipokine Expression on Tumor Characteristics and Survival Outcomes in Patients with Renal Cell Carcinoma.

Oktay Halit Aktepe, Tugce Ulasli, Aytac Terzi

|Mar 22, 2025
Achieving treatment goals in older breast cancer patients receiving neoadjuvant chemotherapy.

Eda Caliskan Yildirim, Elif Atag, Huseyin Salih Semiz

|Oct 09, 2023
Treatment Outcomes and Prognostic Factors in N3 Stage Gastric Cancer After Curative Resection: A Real World Data.

Eda Caliskan Yildirim, Yusuf Acikgoz, Yakup Ergun

|Nov 14, 2019
KRAS codon 12 and 13 mutations may guide the selection of irinotecan or oxaliplatin in first-line treatment of metastatic colorectal cancer.

Yakup Ergun, Yusuf Acikgoz, Oznur Bal

Pageof 1

Frequent Collaborators

2 joint publications

Yakup Ergun

2 joint publications

Yusuf Acikgoz

2 joint publications

Oktay Halit Aktepe

1 joint publications

Oznur Bal